Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $3.13 USD
Change Today -0.16 / -4.86%
Volume 149.9K
GALT On Other Exchanges
Symbol
Exchange
NASDAQ CM
Frankfurt
As of 8:10 PM 04/27/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Arthur R. Greenberg

Director, Member of Audit Committee and Member of Nominating & Corporate Governance Committee, Galectin Therapeutics, Inc.
AgeTotal Calculated CompensationThis person is connected to 11 board members in 1 different organizations across 1 different industries.

See Board Relationships
67--

Background*

Mr. Arthur R. Greenberg, also known as Bobby is the Founder of Prism Technologies, Inc. and serves as its President. Previously, Mr. Greenberg served as the President of SEMI, North America. He served as a Founding Member of Semiconductor Systems, Inc. in 1982. He served as a Founding Memberand Vice President of Sales & Marketing at KTI Chemicals, Inc., since 1973. Mr. Greenberg has 37 years experience in the semiconductor equipment and materials industries. He has ...

Read Full Background

Corporate Headquarters*

4960 Peachtree Industrial Boulevard
Norcross, Georgia 30071

United States

Phone: 678-620-3186
Fax: 770-864-1327

Board Members Memberships*

2009-Present
Director, Member of Audit Committee and Member of Nominating & Corporate Governance Committee

Education*

BS
Henderson State University

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
GALT:US $3.13 USD -0.16

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact GALECTIN THERAPEUTICS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.